+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertension



Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertension



Clinics 68(11): 1428-1432



The angiotensin-converting enzyme gene is one of the most studied candidate genes related to atrial fibrillation. Among the polymorphisms of the angiotensin-converting enzyme gene, the 2350 G/A polymorphism (rs4343) is known to have the most significant effects on the plasma angiotensin-converting enzyme concentration. The aim of the present study was to investigate the association of the angiotensin-converting enzyme 2350 G/A polymorphism with atrial fibrillation in Han Chinese patients with essential hypertension. A total of 169 hypertensive patients were eligible for this study. Patients with atrial fibrillation (n = 75) were allocated to the atrial fibrillation group, and 94 subjects without atrial fibrillation were allocated to the control group. The PCR-based restriction fragment length polymorphism technique was used to assess the genotype frequencies. The distributions of the angiotensin-converting enzyme 2350 G/A genotypes (GG, GA, and AA, respectively) were 40.43%, 41.49%, and 18.08% in the controls and 18.67%, 46.67%, and 34.66% in the atrial fibrillation subjects (p = 0.037). The frequency of the A allele in the atrial fibrillation group was significantly greater than in the control group (58.00% vs. 38.83%, p = 0.0007). Compared with the wild-type GG genotype, the GA and AA genotypes had an increased risk for atrial fibrillation. Additionally, atrial fibrillation patients with the AA genotype had greater left atrial dimensions than the patients with the GG or GA genotypes (p<0.01 and p<0.05, respectively). The results obtained in this study indicate that the angiotensin-converting enzyme 2350 G/A polymorphism is associated with atrial fibrillation and that the A allele shows an increased risk for atrial fibrillation in Han Chinese patients with essential hypertension.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 051549617

Download citation: RISBibTeXText

PMID: 24270955


Related references

Angiotensin-converting enzyme gene 2350 G/A polymorphism is associated with left ventricular hypertrophy but not essential hypertension. Hypertension Research 30(1): 31-37, 2007

Association of angiotensin I-converting enzyme gene polymorphism with ACE and PAI-1 levels in Guangdong Chinese Han patients with essential hypertension. Nan Fang Yi Ke Da Xue Xue Bao 27(11): 1681-1684, 2007

Association of angiotensin-converting enzyme gene 2350 G/A polymorphism with diabetic retinopathy in Chinese Han population. Molecular Biology Reports 40(1): 463-468, 2013

Association of angiotensin I converting enzyme 2 gene polymorphism with essential hypertension in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22(5): 569-571, 2005

Deletion polymorphism in the angiotensin converting enzyme gene associated with essential hypertension in Hans Chinese population. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 20(2): 133-137, 2001

Lack of association of the angiotensin converting enzyme gene polymorphism with essential hypertension in a Chinese population. American Journal Of Hypertension. 10(2): 201, 1997

Angiotensin I converting enzyme gene polymorphism in Chinese patients with hypertension. American Journal Of Hypertension. 10(5 Part 1): 558-561, 1997

Angiotensin-converting enzyme gene polymorphism in untreated essential hypertension and response to angiotensin converting enzyme inhibitors. Yaoxue Xuebao 34(9): 655-657, Sept 28, 1999

The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia. Annales Academiae Medicae Stetinensis 51(1): 95-105, 2006

Angiotensin-converting enzyme gene insertion/deletion polymorphism and essential hypertension in the Chinese population: a meta-analysis including 21,058 participants. Internal Medicine Journal 42(4): 439-444, 2013

Endothelial function and I/D polymorphism of angiotensin converting enzyme gene in patients with essential hypertension. Kardiologiia 47(6): 54-55, 2008

Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension. American Journal of Hypertension 12(10 PART 1): 1038-1043, 1999

Polymorphisms of angiotensin-converting enzyme 2 gene confer a risk to lone atrial fibrillation in Chinese male patients. Chinese Medical Journal 126(24): 4608-4611, 2014

Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism Clinical & Experimental 50(11): 1346-1350, 2001

Polymorphism of angiotensin converting enzyme gene is associated with hemostatic parameters disturbances in patients with essential hypertension. Journal of the American College of Cardiology 33(2 SUPPL A): 285A, 1999